43857-0405 NDC - PNEUMOTOX (TRITICUM AESTIVUM, ALFALFA, ARNICA MONTANA, ASCLEPIAS TUBEROSA, CHAMOMILLA, ECHINACEA (ANGUSTIFOLIA), EUCALYPTUS GLOBULUS, FUCUS VESICULOSUS, HORDEUM VULGARE, LAMINARIA DIGITATA, NASTURTIUM AQUATICUM, PLANTAGO MAJOR, RAPHANUS SATIVUS, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, SYMPHYTUM OFFICINALE, LUNG (SUIS), ORYZA SATIVA, SILICEA, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, SODIUM BENZENE SULFONATE, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM)

Drug Information

Product NDC: 43857-0405

Proprietary Name: Pneumotox

Non Proprietary Name: Triticum Aestivum, Alfalfa, Arnica Montana, Asclepias Tuberosa, Chamomilla, Echinacea (Angustifolia), Eucalyptus Globulus, Fucus Vesiculosus, Hordeum Vulgare, Laminaria Digitata, Nasturtium Aquaticum, Plantago Major, Raphanus Sativus, Trifolium Pratense, Trigonella Foenum-Graecum, Symphytum Officinale, Lung (Suis), Oryza Sativa, Silicea, Acetone, Sodium Tripolyphosphate, Propylene Glycol, Sodium Benzene Sulfonate, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Arsenicum Album

Active Ingredient(s):
  • 9 [hp_X]/mL ACETONE;
  • 3 [hp_X]/mL ALFALFA;
  • 9 [hp_X]/mL AMMONIUM CHLORIDE;
  • 30 [hp_X]/mL AMMONIUM THIOGLYCOLATE;
  • 30 [hp_X]/mL ANHYDROUS CITRIC ACID;
  • 30 [hp_X]/mL ANTHRAQUINONE;
  • 3 [hp_X]/mL ARNICA MONTANA;
  • 12 [hp_X]/mL ARSENIC TRIOXIDE;
  • 3 [hp_X]/mL ASCLEPIAS TUBEROSA ROOT;
  • 30 [hp_X]/mL DIMETHICONE;
  • 3 [hp_X]/mL ECHINACEA ANGUSTIFOLIA;
  • 30 [hp_X]/mL ETHYLENE GLYCOL;
  • 3 [hp_X]/mL EUCALYPTUS GLOBULUS LEAF;
  • 3 [hp_X]/mL FUCUS VESICULOSUS;
  • 30 [hp_X]/mL GLUTARAL;
  • 30 [hp_X]/mL GLYCOLIC ACID;
  • 3 [hp_X]/mL HORDEUM VULGARE TOP;
  • 30 [hp_X]/mL HYDROGEN PEROXIDE;
  • 3 [hp_X]/mL LAMINARIA DIGITATA;
  • 3 [hp_X]/mL MATRICARIA RECUTITA;
  • 30 [hp_X]/mL METHYL METHACRYLATE;
  • 30 [hp_X]/mL MONOETHANOLAMINE;
  • 3 [hp_X]/mL NASTURTIUM OFFICINALE;
  • 12 [hp_X]/mL NITRIC ACID;
  • 12 [hp_X]/mL OENANTHE AQUATICA FRUIT;
  • 8 [hp_X]/mL ORYZA SATIVA WHOLE;
  • 30 [hp_X]/mL P-AMINOPHENOL;
  • 30 [hp_X]/mL PALMITIC ACID;
  • 30 [hp_X]/mL PARAFFIN;
  • 12 [hp_X]/mL PHOSPHORIC ACID;
  • 12 [hp_X]/mL PHOSPHORUS;
  • 3 [hp_X]/mL PLANTAGO MAJOR;
  • 30 1/mL POLYACRYLIC ACID (8000 MW);
  • 30 [hp_X]/mL PROPYL ALCOHOL;
  • 9 [hp_X]/mL PROPYLENE GLYCOL;
  • 12 [hp_X]/mL PULSATILLA VULGARIS;
  • 3 [hp_X]/mL RAPHANUS SATIVUS;
  • 8 [hp_X]/mL SILICON DIOXIDE;
  • 9 [hp_X]/mL SODIUM BENZENESULFONATE;
  • 30 [hp_X]/mL SODIUM CARBONATE;
  • 12 [hp_X]/mL SODIUM CHLORIDE;
  • 9 [hp_X]/mL SODIUM LAURYL SULFATE;
  • 9 [hp_X]/mL SODIUM TRIPOLYPHOSPHATE;
  • 8 [hp_X]/mL SUS SCROFA LUNG;
  • 6 [hp_X]/mL SYMPHYTUM OFFICINALE WHOLE;
  • 30 [hp_X]/mL TARTARIC ACID;
  • 30 [hp_X]/mL TOLUENE-2,5-DIAMINE;
  • 12 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF;
  • 3 [hp_X]/mL TRIFOLIUM PRATENSE FLOWER;
  • 3 [hp_X]/mL TRIGONELLA FOENUM-GRAECUM WHOLE;
  • 1 [hp_X]/mL TRITICUM AESTIVUM WHOLE;
  • 9 [hp_X]/mL TURPENTINE OIL


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Acidifying Activity [MoA];
  • Anti-coagulant [EPC];
  • Calcium Chelating Activity [MoA];
  • Calculi Dissolution Agent [EPC];
  • Decreased Coagulation Factor Activity [PE];
  • Sclerosing Activity [MoA];
  • Sclerosing Agent [EPC];
  • Skin Barrier Activity [PE];
  • Vascular Sclerosing Activity [PE]

Labeler Information

Labeler Name: BioActive Nutritional, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/3/2016
End Marketing Date:6/29/2023

Package Information

No. Package Code Package Description Billing Unit
143857-0405-130 mL in 1 BOTTLE, DROPPER (43857-0405-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43857-0405The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEPneumotoxThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMETriticum Aestivum, Alfalfa, Arnica Montana, Asclepias Tuberosa, Chamomilla, Echinacea (Angustifolia), Eucalyptus Globulus, Fucus Vesiculosus, Hordeum Vulgare, Laminaria Digitata, Nasturtium Aquaticum, Plantago Major, Raphanus Sativus, Trifolium Pratense, Trigonella Foenum-Graecum, Symphytum Officinale, Lung (Suis), Oryza Sativa, Silicea, Acetone, Sodium Tripolyphosphate, Propylene Glycol, Sodium Benzene Sulfonate, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Arsenicum AlbumThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/3/2016This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE6/29/2023This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBioActive Nutritional, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACETONE; ALFALFA; AMMONIUM CHLORIDE; AMMONIUM THIOGLYCOLATE; ANHYDROUS CITRIC ACID; ANTHRAQUINONE; ARNICA MONTANA; ARSENIC TRIOXIDE; ASCLEPIAS TUBEROSA ROOT; DIMETHICONE; ECHINACEA ANGUSTIFOLIA; ETHYLENE GLYCOL; EUCALYPTUS GLOBULUS LEAF; FUCUS VESICULOSUS; GLUTARAL; GLYCOLIC ACID; HORDEUM VULGARE TOP; HYDROGEN PEROXIDE; LAMINARIA DIGITATA; MATRICARIA RECUTITA; METHYL METHACRYLATE; MONOETHANOLAMINE; NASTURTIUM OFFICINALE; NITRIC ACID; OENANTHE AQUATICA FRUIT; ORYZA SATIVA WHOLE; P-AMINOPHENOL; PALMITIC ACID; PARAFFIN; PHOSPHORIC ACID; PHOSPHORUS; PLANTAGO MAJOR; POLYACRYLIC ACID (8000 MW); PROPYL ALCOHOL; PROPYLENE GLYCOL; PULSATILLA VULGARIS; RAPHANUS SATIVUS; SILICON DIOXIDE; SODIUM BENZENESULFONATE; SODIUM CARBONATE; SODIUM CHLORIDE; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; SUS SCROFA LUNG; SYMPHYTUM OFFICINALE WHOLE; TARTARIC ACID; TOLUENE-2,5-DIAMINE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; TRIGONELLA FOENUM-GRAECUM WHOLE; TRITICUM AESTIVUM WHOLE; TURPENTINE OILAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH9; 3; 9; 30; 30; 30; 3; 12; 3; 30; 3; 30; 3; 3; 30; 30; 3; 30; 3; 3; 30; 30; 3; 12; 12; 8; 30; 30; 30; 12; 12; 3; 30; 30; 9; 12; 3; 8; 9; 30; 12; 9; 9; 8; 6; 30; 30; 12; 3; 3; 1; 9 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAcidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Sclerosing Activity [MoA], Sclerosing Agent [EPC], Skin Barrier Activity [PE], Vascular Sclerosing Activity [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023